DIA has made a strategic investment in Claritype, an AI-powered data integration platform, to enhance efficiency and decision-making in the dental analytics sector.
Information on the Target
Claritype is an innovative artificial intelligence (AI) data integration and analytics platform focused on the multi-site healthcare industry, particularly in dental practices. The platform provides a solution for the widespread issue of fragmented data across various systems, including practice management, accounting, and telecommunications. By utilizing advanced AI technology, Claritype helps provider organizations generate actionable insights and comprehensive reports that facilitate real-time strategic decision-making.
Launched in late 2024, Claritype's flagship product, Visio360, empowers dental providers to harness the power of structured data from multiple enterprise systems. This allows practices to efficiently analyze their data through sophisticated analytics, dashboards, and visualization tools, thereby turning raw data into strategic advantages while avoiding the disruptive costs associated with converting acquired practices to a unified practice management system.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The dental analytics sector operates within the broader multi-site healthcare market, which exceeds $1 trillion in value. This industry has been facing significant challenges due to data fragmentation, making it difficult for provider organiz
Similar Deals
Rittenhouse Ventures → S2N Health, Inc.
2025
Dental Innovation Alliance (DIA) → Perceptive
2025
One Eight Capital → Sollis Health
2025
Alzheimer’s Drug Discovery Foundation → Transposon Therapeutics
2025
DIA
invested in
Claritype
in 2025
in a Other VC deal